A newly identified driver of melanoma growth not only promotes tumor blood supply but also helps tumors evade immune attack.

NEW YORK, Feb. 11, 2026 /PRNewswire/ -- A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors' ability to evade attack by the body's immune system, a ...

A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors' ability to evade ...

INDICATIONS EYLEA HD ® (aflibercept) Injection 8 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), and ...

Merck to present data across multiple genitourinary cancers from several approved and investigational medicines at 2026 ASCO GU cancers symposium: Rahway, New Jersey Saturday, Feb ...

Analysis of the final APEX Phase 1b clinical results obtained with KSI-101 (Kodiak Sciences Inc.) evaluated to treat macular edema secondary to inflammation (MESI) showed that at week 24 well over ...

We drink tea and coffee to stay alert or for comfort but ahead of World Cancer Day 2026 a doctor explains how your daily brew ...

Following a detailed evaluation of global Phase III clinical data and safety findings of Fruquintinib 1 mg and 5 mg Hard ...

An Indian review reveals how macrophages are reprogrammed inside breast tumours, helping cancer grow and spread while opening new treatment pathways.

The mechanism remains unclear, but GLP-1 users had less MACE, CV death, and all-cause death driven by fewer amputations.